← Browse by Condition
Medical Condition

ras kras or nras gene mutation

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT06229340 Phase 2
Recruiting

Leflunomide or Combination of MEK Inhibitor and Hydroxychloroquine for Refractory Patients With RAS Mutations

Enrollment
20 pts
Location
Russia
Sponsor
N.N. Petrov National Medical R...
View Trial →